FALSINI, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 1.652
EU - Europa 812
AS - Asia 413
SA - Sud America 18
OC - Oceania 9
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 2.913
Nazione #
US - Stati Uniti d'America 1.647
RU - Federazione Russa 289
IT - Italia 131
IE - Irlanda 128
HK - Hong Kong 113
SG - Singapore 106
PL - Polonia 102
SE - Svezia 87
CN - Cina 78
VN - Vietnam 40
IN - India 33
JO - Giordania 21
DE - Germania 19
ES - Italia 19
BR - Brasile 17
ID - Indonesia 11
GB - Regno Unito 10
AU - Australia 9
FI - Finlandia 9
UA - Ucraina 6
NL - Olanda 5
BE - Belgio 4
EU - Europa 4
JP - Giappone 4
CA - Canada 3
CI - Costa d'Avorio 3
KR - Corea 3
TR - Turchia 2
AR - Argentina 1
CH - Svizzera 1
CR - Costa Rica 1
EE - Estonia 1
EG - Egitto 1
JM - Giamaica 1
LT - Lituania 1
MA - Marocco 1
PK - Pakistan 1
SY - Repubblica araba siriana 1
Totale 2.913
Città #
Santa Clara 553
Fairfield 149
Chandler 141
Dublin 128
Warsaw 102
Ashburn 96
Hong Kong 94
Woodbridge 74
Houston 71
Seattle 66
Cambridge 62
Wilmington 58
Singapore 53
Florence 47
Dong Ket 40
Ann Arbor 36
Mumbai 30
Princeton 29
Beijing 24
Altamura 23
Lawrence 23
Shanghai 19
Barcelona 17
Boston 14
Falls Church 11
Jakarta 11
Medford 11
Moscow 10
San Diego 10
Gavirate 9
Melbourne 9
New York 8
Boardman 7
Cagliari 7
Kent 7
Jacksonville 6
Buffalo 5
Guangzhou 5
Brussels 4
Jinan 4
Los Angeles 4
Parma 4
Abidjan 3
Helsinki 3
Munich 3
Norwalk 3
Pontassieve 3
Pune 3
Toronto 3
Camerino 2
Curitiba 2
Ferrara 2
Hefei 2
Hillsboro 2
Icheon-si 2
London 2
Nanjing 2
Redwood City 2
Stia 2
Trumbull 2
West Jordan 2
Wuhan 2
Yubileyny 2
Acaraú 1
Andover 1
Aracaju 1
Augusta 1
Belo Horizonte 1
Böblingen 1
Cairo 1
Casablanca 1
Castelfranco di Sotto 1
Cavarzere 1
Chengdu 1
Chongqing 1
Chuxiong 1
Dalian 1
Damascus 1
Estância 1
Hebei 1
Indaiatuba 1
Ipatinga 1
Iporá 1
Islamabad 1
Islington 1
Kingston 1
Kunming 1
Lajinha 1
Lappeenranta 1
Madrid 1
Milan 1
Misano Adriatico 1
Nottingham 1
Pedro Leopoldo 1
Posadas 1
Quanzhou 1
Rio de Janeiro 1
Rome 1
Romola 1
Rotterdam 1
Totale 2.167
Nome #
The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A2A Receptor Subtype 221
Design and synthesis of new adenosine receptor antagonists as neuroprotective agents 173
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles 170
Imidazo[1,2-a]pyrazin-8-amine core for the design of new adenosine receptor antagonists: Structural exploration to target the A3 and A2A subtypes 148
Modifications on the Amino-3,5-dicyanopyridine Core To Obtain Multifaceted Adenosine Receptor Ligands with Antineuropathic Activity 140
Structural investigations on coumarins leading to chromeno[4,3-c]pyrazol-4-ones and pyrano[4,3-c]pyrazol-4-ones: New scaffolds for the design of the tumor-associated carbonic anhydrase isoforms IX and XII 140
3-Hydroxy-1H-quinazoline-2,4-dione as a New Scaffold to Develop Potent and Selective Inhibitors of the Tumor-Associated Carbonic Anhydrases IX and XII 138
Development of novel pyridazinone-based adenosine receptor ligands 137
Antioxidant-Conjugated 1,2,4-Triazolo[4,3-a]pyrazin-3-one Derivatives: Highly Potent and Selective Human A2A Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic Pain 134
Design, synthesis, and pharmacological characterization of 2‑(2- furanyl)thiazolo[5,4‑d]pyrimidine-5,7-diamine derivatives: new highly potent A2A adenosine receptor inverse agonists with antinociceptive activity 131
Exploring the 2- and 5-positions of the pyrazolo[4,3-d]pyrimidin-7-amino scaffold to target human A1 and A2A adenosine receptors 125
The aminopyridine-3,5-dicarbonitrile core for the design of new non-nucleoside-like agonists of the human adenosine A2Breceptor 121
New 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives. Evaluation of different moieties on the 6-aryl ring to obtain potent and selective human A2A adenosine receptor antagonists 118
Novel 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as potent human adenosine A 1 and A 2A receptor antagonists. Evaluation of their protective effect against β-amyloid-induced neurotoxicity in SH-SY5Y cells 117
Novel human adenosine receptor antagonists based on the 7-amino-thiazolo[5,4-d]pyrimidine scaffold. Structural investigations at the 2-, 5- and 7-positions to enhance affinity and tune selectivity 115
Structural refinement of pyrazolo[4,3-d]pyrimidine derivatives to obtain highly potent and selective antagonists for the human A3 adenosine receptor 105
2-Aryl-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as new potent adenosine human A2A receptor antagonists 103
Structure-activity relationship studies and pharmacological characterization of N5-heteroarylalkyl-substituted-2-(2-furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine-based derivatives as inverse agonists at human A2Aadenosine receptor 97
Thiazolo[5,4-d]pyrimidin-7-amino derivatives as dual human adenosine A2A/A1 receptor antagonists. 97
3-Hydroxy-1H-quinazoline-2,4-dione derivatives as new potent and selective inhibitors of the tumor-associated carbonic anhydrase IX and XII. 92
Identification of novel thiazolo[5,4-d]pyrimidine derivatives as human A1and A2Aadenosine receptor antagonists/inverse agonists 92
Aminopyridine-3,5-carbonitrile core for the design of new adenosine receptor agonists: structural exploration to target the A1 subtype 91
New aminopyridine-3,5-dicarbonitirles as adenosine A2B receptor non-nucleoside agonists. 90
New 5-heteroaryl-pyrazolo[4,3-d]pyrimidin-7-amines as dual human adenosine A1 and A2A receptor antagonists. 84
Crystal Structure and Subsequent Ligand Design of a Nonriboside Partial Agonist Bound to the Adenosine A2A Receptor 4
Totale 2.983
Categoria #
all - tutte 8.568
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.568


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202076 0 0 0 0 0 0 0 0 0 38 29 9
2020/2021277 10 30 3 33 18 14 7 16 33 48 22 43
2021/2022185 6 12 27 4 6 8 7 13 6 17 30 49
2022/2023522 43 90 45 30 36 96 62 44 56 0 15 5
2023/2024219 5 20 23 10 7 53 9 48 10 18 10 6
2024/20251.219 30 151 71 152 440 213 14 86 62 0 0 0
Totale 2.983